Mercks Belzutifan Approved for Treating VHL-Related Cancers
| STVTX Fund | USD 12.80 0.01 0.08% |
Slightly above 56% of Ridgeworth Ceredex's investor base is looking to short. The analysis of overall sentiment of trading Ridgeworth Ceredex Large mutual fund suggests that many investors are alarmed at this time. Ridgeworth Ceredex's investing sentiment can be driven by a variety of factors including economic data, Ridgeworth Ceredex's earnings reports, geopolitical events, and overall market trends.
Ridgeworth |
The National Medical Products Administration has approved Mercks Belzutifan tablets for the treatment of von Hippel-Lindau disease-associated renal
Read at gurufocus.com
 |
Ridgeworth Ceredex Fundamental Analysis
We analyze Ridgeworth Ceredex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ridgeworth Ceredex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ridgeworth Ceredex based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Minimum Initial Investment
Minimum Initial Investment Comparative Analysis
Minimum Initial Investment refers to minimum amount the fund family or category will require an investor to deposit to acquire the very first position in the fund or to open an account. In other words, Minimum Initial Investment is a guarantee that any investment from a purchaser of a fund meets the minimum requirement of the fund.
Ridgeworth Ceredex Large Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ridgeworth Ceredex mutual fund to make a market-neutral strategy. Peer analysis of Ridgeworth Ceredex could also be used in its relative valuation, which is a method of valuing Ridgeworth Ceredex by comparing valuation metrics with similar companies.
Peers
Ridgeworth Ceredex Related Equities
| AAARX | Strategic Allocation: | 0.57 | ||||
| MSTSX | Morningstar Unconstrained | 0.25 | ||||
| TFCCX | Touchstone Large | 0.05 | ||||
| RETSX | Tax-managed | 0.34 | ||||
| JDVNX | Jhancock Disciplined | 0.43 | ||||
| LMUSX | Qs Us | 0.50 | ||||
| KLCKX | Federated Kaufmann | 0.80 |
Other Information on Investing in Ridgeworth Mutual Fund
Ridgeworth Ceredex financial ratios help investors to determine whether Ridgeworth Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ridgeworth with respect to the benefits of owning Ridgeworth Ceredex security.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |